Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
National Institute on Drug Abuse (NIDA) |
---|---|
Information provided by: | National Institute on Drug Abuse (NIDA) |
ClinicalTrials.gov Identifier: | NCT00067535 |
The purpose of this study is to assess Potential Interactions Between iv Cocaine and RPR 102681
Condition | Intervention | Phase |
---|---|---|
Cocaine-Related Disorders |
Drug: Cocaine-Related Disorders |
Phase I |
Study Type: | Interventional |
Study Design: | Diagnostic, Randomized, Double-Blind, Placebo Control, Single Group Assignment, Safety Study |
Official Title: | Potential Interactions Between IV Cocaine and RPR 102681 |
Ages Eligible for Study: | 18 Years to 45 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Includes but is not limited to:
Exclusion Criteria:
Please contact site for more information.
United States, Maryland | |
Uniformed Services University of Health Science | |
Bethesda, Maryland, United States, 20814 4799 |
Principal Investigator: | Louis Cantilena, M.D. | Uniformed Services University of Health Science |
Study ID Numbers: | NIDA-CPU-0003-1 |
Study First Received: | August 21, 2003 |
Last Updated: | October 23, 2007 |
ClinicalTrials.gov Identifier: | NCT00067535 |
Health Authority: | United States: Food and Drug Administration |
Cocaine-Related Disorders Dopamine Mental Disorders |
Substance-Related Disorders Disorders of Environmental Origin Cocaine |
Dopamine Uptake Inhibitors Neurotransmitter Agents Neurotransmitter Uptake Inhibitors Molecular Mechanisms of Pharmacological Action Physiological Effects of Drugs Anesthetics Central Nervous System Depressants Cardiovascular Agents |
Pharmacologic Actions Anesthetics, Local Sensory System Agents Therapeutic Uses Vasoconstrictor Agents Dopamine Agents Peripheral Nervous System Agents Central Nervous System Agents |